ATE227293T1

Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 1 May 2017, 9.4 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

16 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims1

Priority claims
DocumentOfficeKindDate
1773796United States of AmericaP

Members16

Family members, oldest first
DocumentOfficeKind
CA2205274A1CanadaA1
EP0807633A2European Patent Office (EPO)A2
JPH1045757AJapanA
EP0807633A3European Patent Office (EPO)A3
MX9703610AMexicoA
US5962457AUnited States of AmericaA
JP3270360B2JapanB2
EP0807633B1European Patent Office (EPO)B1
AT227293TAustriaT
ATE227293T1This recordAustriaT1
DK0807633T3DenmarkT3
DE69716810D1GermanyD1
CA2205274CCanadaC
DE69716810T2GermanyT2
PT807633EPortugalE
ES2184960T3SpainT3